Business Mangement

 Chip makers Nvidia (NVDA) and AMD (AMD) are falling about 3% and 5%, respectively today.

Qualcomm (QCOM) indicated that it could look to compete with Nvidia in the PC graphics sector, while Goldman Sachs downgraded AMD stock.

Qualcomm Could Look to Take Market Share From Nvidia

Qualcomm CEO Cristiano Amon told Yahoo Finance that his company was seeking to begin marketing top-notch PC graphics chips. The latter products are among Nvidia's core offerings, as the chip giant reportedly has an 88% share "of the desktop graphics space."

Goldman Cuts Its Rating on AMD

Goldman lowered its rating on AMD to Neutral from Buy and slashed its price target on the shares to $129 from $175.

As reasons for the downgrade, Goldman cited lower demand for AMD's PC and server chips, along with its weaker-than-expected revenue from data centers. The bank wrote that it is "increasingly concerned" about the competition that AMD is facing from Arm-based chips, along with its generally tough competition.

According to Goldman, these negative catalysts may weigh on the valuation of AMD stock.

The Recent Price Action of Nvidia and AMD

Nvidia is down 1.5% in the last month, while the shares are little changed in the past three months. As for AMD, it has sunk 11.5% and 30% during the same time periods.

While we acknowledge the potential of NVDA, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NVDA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ ALSO 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock Disclosure: None. This article is originally published at Insider Monkey.

 McKesson shared that it is committed to awarding funding to eligible state pharmacy associations across all 50 states to help meet association advocacy goals through McKesson Amplify. 

McKesson Amplify is a strategic initiative intended to help protect critical pharmacy services and elevate the pharmacy profession by strengthening the voice of the industry. 

“We believe pharmacists’ voices are one of the most important in the conversation. But, a single voice can only be heard from so far,” said Jeanine Singer, senior vice president, national and key accounts and field sales at McKesson. “Recognizing that advocacy and pharmacy practice transformation happens locally, we created McKesson Amplify to collectively raise the profession and turn up the volume in support of independent community pharmacy across the nation.”

To determine funding awards, McKesson reviewed applications from state pharmacy associations, which detailed activation ideas and goals. State pharmacy associations shared their creativity and commitment to the profession of pharmacy, with common requests for funding centering around:

Advocacy and lobbying: Strengthening legislative influence in support of beneficial legislation for the pharmacy profession.

Events: Promoting the essential role of the pharmacy and pharmacists to key local stakeholders through legislative days, annual association meetings and other advocacy gatherings.

Membership drives: Increasing and engaging membership through targeted campaigns and recruitment events.

Professional development and training: Elevating the role of pharmacists through leadership training, advocacy education and practice advancement resources.

Communications, technology and digital platforms: Supporting state association advocacy efforts.

Krystalynn Weaver, executive vice president and CEO of the National Alliance of State Pharmacy Associations, said, “The strategic thinking and the innovative ideas from each of the state associations will rocket all of our state pharmacy associations to think bigger, aim further and do more than they ever would have done if it weren’t for the McKesson Amplify program.”

Beyond funding, McKesson Amplify also will provide resources, strategic support and other tools to help state pharmacy associations achieve their local and state advocacy goals in 2025.

View the full list of state pharmacy associations benefiting from McKesson Amplify on McKesson.com. Community pharmacists and their teams are encouraged to join and engage with their state pharmacy association.